title: Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
authors.forename: R
authors.initials: R
authors.lastname: Cunningham
mesh_terms: D016026:Bone Marrow Transplantation / Q000191:economics*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy*; D002140:California; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005260:Female; D006279:Health Maintenance Organizations / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D019458:Insurance Coverage / Q000331:legislation & jurisprudence*; D011785:Quality Assurance, Health Care; D012306:Risk; D014182:Transplantation, Autologous / Q000191:economics; D014481:United States